Literature DB >> 15487592

Lassa virus.

Stephan Günther1, Oliver Lenz.   

Abstract

Lassa virus is a RNA virus belonging to the family of Arenaviridae. It was discovered as the causative agent of a hemorrhagic fever--Lassa fever--about 30 years ago. Lassa fever is endemic in West Africa and is estimated to affect some 100,000 people annually. Great progress in the understanding of the life cycle of arenaviruses, including Lassa virus, has been made in recent years. New insights have been gained in the pathogenesis and molecular epidemiology of Lassa fever, and state-of the-art technologies for diagnosing this life-threatening disease have been developed. The intention of this review is to summarize in particular the recent literature on Lassa virus and Lassa fever. Several aspects ranging from basic research up to clinical practice and laboratory diagnosis are discussed and linked together.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15487592     DOI: 10.1080/10408360490497456

Source DB:  PubMed          Journal:  Crit Rev Clin Lab Sci        ISSN: 1040-8363            Impact factor:   6.250


  91 in total

1.  Improved detection of Lassa virus by reverse transcription-PCR targeting the 5' region of S RNA.

Authors:  Stephan Olschläger; Michaela Lelke; Petra Emmerich; Marcus Panning; Christian Drosten; Meike Hass; Danny Asogun; Deborah Ehichioya; Sunday Omilabu; Stephan Günther
Journal:  J Clin Microbiol       Date:  2010-03-29       Impact factor: 5.948

2.  Domain structure of Lassa virus L protein.

Authors:  Linda Brunotte; Michaela Lelke; Meike Hass; Katja Kleinsteuber; Beate Becker-Ziaja; Stephan Günther
Journal:  J Virol       Date:  2010-10-27       Impact factor: 5.103

3.  Generation of recombinant arenavirus for vaccine development in FDA-approved Vero cells.

Authors:  Benson Y H Cheng; Emilio Ortiz-Riaño; Juan Carlos de la Torre; Luis Martínez-Sobrido
Journal:  J Vis Exp       Date:  2013-08-01       Impact factor: 1.355

4.  Genome comparison of virulent and avirulent strains of the Pichinde arenavirus.

Authors:  Shuiyun Lan; Lisa McLay; Judy Aronson; Hinh Ly; Yuying Liang
Journal:  Arch Virol       Date:  2008-05-28       Impact factor: 2.574

5.  Change in blood test after irradiation with high doses for inactivation of Lassa virus.

Authors:  K Eberlein; G Hintereder; S Schilling; C Rödel; L Jüling-Pohlit
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-08-26       Impact factor: 3.267

6.  Lassa virus nucleoprotein mutants generated by reverse genetics induce a robust type I interferon response in human dendritic cells and macrophages.

Authors:  Xavier Carnec; Sylvain Baize; Stéphanie Reynard; Laure Diancourt; Valérie Caro; Noel Tordo; Michèle Bouloy
Journal:  J Virol       Date:  2011-08-31       Impact factor: 5.103

7.  A recently isolated Lassa virus from Mali demonstrates atypical clinical disease manifestations and decreased virulence in cynomolgus macaques.

Authors:  David Safronetz; James E Strong; Friederike Feldmann; Elaine Haddock; Nafomon Sogoba; Douglas Brining; Thomas W Geisbert; Dana P Scott; Heinz Feldmann
Journal:  J Infect Dis       Date:  2013-01-09       Impact factor: 5.226

8.  Stimulation of Ebola virus production from persistent infection through activation of the Ras/MAPK pathway.

Authors:  James E Strong; Gary Wong; Shane E Jones; Allen Grolla; Steven Theriault; Gary P Kobinger; Heinz Feldmann
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-03       Impact factor: 11.205

9.  T cell-dependence of Lassa fever pathogenesis.

Authors:  Lukas Flatz; Toni Rieger; Doron Merkler; Andreas Bergthaler; Tommy Regen; Mariann Schedensack; Lukas Bestmann; Admar Verschoor; Mario Kreutzfeldt; Wolfgang Brück; Uwe-Karsten Hanisch; Stephan Günther; Daniel D Pinschewer
Journal:  PLoS Pathog       Date:  2010-03-26       Impact factor: 6.823

10.  Prevalence and risk factors of Lassa seropositivity in inhabitants of the forest region of Guinea: a cross-sectional study.

Authors:  Solen Kernéis; Lamine Koivogui; N'Faly Magassouba; Kekoura Koulemou; Rosamund Lewis; Aristide Aplogan; Rebecca F Grais; Philippe J Guerin; Elisabeth Fichet-Calvet
Journal:  PLoS Negl Trop Dis       Date:  2009-11-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.